Sino Biopharmaceutical Ltd - Cost of Goods Sold Including Depreciation and Amortization

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 5.50 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025.

Sino Biopharmaceutical Ltd's second quarter result of 1.54 Billion HKD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents no change compared to it's first quarter result.

Also, Sino Biopharmaceutical Ltd's second quarter result of 1.54 Billion HKD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 16.34 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 5.50 Billion HKD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 4.10 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 28.40 percent compared to the value the year prior.
The 1 year change in percent is 28.40.
The 3 year change in percent is -0.732.
The 5 year change in percent is 4.40.
The 10 year change in percent is 106.37.

The Serie's long term average value is 3.57 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 53.87 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2011, to it's latest available value, on 06/30/2025, is +458.44%.
The Serie's change in percent from it's maximum value, on 09/30/2022, to it's latest available value, on 06/30/2025, is -2.98%.